What counts as a Serious Risk under EU market surveillance rules?
A serious-risk decision requires more than a finding that a product is non-compliant. The MSR definition combines the probability that a hazard will cause harm with the severity of that harm and asks whether rapid authority intervention is required. The effects of the risk do not have to be immediate. Article 19 then requires an appropriate assessment of the nature of the hazard and the likelihood of its occurrence.
Where the product presents a , market surveillance authorities must ensure or when no other effective measure can eliminate the risk, or prohibit the product from being made available on the market. Article 16 also allows proportionate corrective action such as bringing the product into compliance, preventing further availability, warnings, public alerts, withdrawal, recall, destruction, or restrictions. Warnings, prior conditions, and end-user alerts may be required only where the product presents a risk in certain conditions or only to certain end users.
- Frame the assessment around the product, hazard, affected end users, normal and foreseeable use, probability, severity, and available technical or incident evidence.
- Separate from lower-risk non-compliance: the trigger is the need for rapid intervention, not the mere existence of safer alternatives or a higher possible safety level.
- Keep the authority-measure record precise: prevents further supply-chain availability; seeks return from end users; prohibition or restriction blocks market availability.
What counts as a under EU market surveillance rules?
A product presents a when an appropriate risk assessment shows that the hazard, likelihood of occurrence, foreseeable use, and severity of harm require rapid intervention by market surveillance authorities. That can lead to , , prohibition, restriction, warnings, or other corrective action, depending on what is effective and proportionate. Authority-required warnings, prior conditions, and end-user alerts under Article 16(3)(e) to (g) are limited to risks arising only in certain conditions or only to certain end users.
What evidence should support a decision under the EU Market Surveillance Regulation?
Keep the risk assessment, product identification, supply-chain and economic-operator details, test results, incident or complaint evidence, technical documentation, corrective-action plan, or evidence, authority correspondence, and any Safety Gate, RAPEX, or ICSMS references used by authorities.
Does formal non-compliance automatically make a product a ?
No. Formal or technical non-compliance can justify corrective action, but Article 19 serious-risk treatment requires an appropriate assessment of the hazard and likelihood showing that rapid authority intervention is needed. The availability of safer products or the feasibility of higher safety alone does not establish a .
When should a serious-risk assessment be repeated?
Repeat the assessment when new incidents, complaints, tests, exposure data, affected-user information, software or product changes, distribution data, foreseeable-use evidence, or corrective-action results change the estimated probability, severity, or need for rapid intervention.
Citations (1)
- Regulation (EU) 2019/1020 on market surveillance
Articles 3, 16, and 19 support the serious-risk definition, risk-assessment basis, and withdrawal, recall, prohibition, restriction, and corrective-action measures.
considered to require rapid intervention